Previous 10 | Next 10 |
Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal Shareholders Advised to Take No Action Pending Board Review PR Newswire HONG KONG , March 2, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" ...
Global Cord Blood Corporation (CO) Q3 2021 Earnings Conference Call February 25, 2021 8:00 AM ET Company Participants Cathy Bai - VP of Corporate Finance Albert Chen - CFO Conference Call Participants Sandy Mehta - Value Investment Principals Cyrille Pichot - Altimeo Asset Management Presenta...
Global Cord Blood had a soft quarter, but subscriber growth continues unabated. This company is very cheap with 156% net cash to market cap. 23% EPS CAGR over the last 5-year period. Its business model follows accrual accounting, leading to high FCF yields of 25%. Cord Blo...
Image source: The Motley Fool. Global Cord Blood Corporation (NYSE: CO) Q3 2021 Earnings Call Feb 25, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Global Cord Blood Corporation (CO) Q3 2021 Earnings Call Transcri...
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021 Added 17,802 New Subscribers in 3Q21 Conference Call to be Held on February 25, 2021, at 8:00 a.m. ET PR Newswire HONG KONG , Feb. 24, 2021 ...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2021 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on February 25, 2021 PR Newswire HONG KONG , Feb. 19, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: ...
The healthcare industry in the United States is expected to become more affordable and innovation-oriented post COVID-19 pandemic, owing to shifting strategies by biopharma companies and the government. We believe relatively lesser known and lower-priced companies, for example Global Cord Blo...
Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal PR Newswire HONG KONG , Feb. 11, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blo...
We identify stocks that are not your conventional market-picks, thereby offering compelling risk/reward. Our stocks have single-digit P/E multiples, high FCF yields, and great net cash to market cap. We generally don't like to follow the "noise on the Street": we like to search fo...
Global Cord Blood ([[CO]] +0.7%) reports that China's National Health Commission or NHC has issued a new policy stating that no applications for cord blood banking licenses in China will be accepted in 2021.In order to improve public health and medical safety and for ...
News, Short Squeeze, Breakout and More Instantly...
Global Cord Blood Corporation Company Name:
CO Stock Symbol:
NYSE Market:
Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the...
Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today announced the Grand Court of the Cayman Islands (the “Court”...
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM PR Newswire HONG KONG , July 6, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provide...